Abstract:Increased matrix stiffness within the colorectal cancer (CRC) tumor microenvironment (TME) has emerged as a pivotal determinant of immunotherapy outcomes. This review discusses the role of aberrant extracellular matrix (ECM) deposition and cross-linking in augmenting matrix stiffness, a phenomenon that not only scaffolds the tumor architecture but also contributes to tumorigenicity and immunologic evasion. Herein, we critically appraise the influence of matrix stiffness on the immunotherapeutic landscape of CRC, focusing on its capacity to impede therapeutic efficacy by modulating immune cell infiltration, activation, and functional performance. The review explores the molecular dynamics whereby matrix stiffness prompts tumor evolution, highlighting the integral role of integrin signaling, cancer-associated fibroblasts (CAFs), and the process of epithelial-mesenchymal transition (EMT). We bring to the fore the paradoxical impact of an indurated ECM on immune effector cells, chiefly T cells and macrophages, which are indispensable for immune surveillance and the execution of immunotherapeutic strategies, yet are markedly restrained by a fibrotic matrix. Furthermore, we examine how matrix stiffness modulates immune checkpoint molecule expression, thereby exacerbating the immunosuppressive milieu within the TME and attenuating immunotherapeutic potency. Emergent therapeutic regimens targeting matrix stiffness-including matrix modulators, inhibitors of mechanotransduction signaling pathways, and advanced biomaterials that mimic the ECM-proffer novel modalities to potentiate immunotherapy responsiveness. By refining the ECM's biomechanical attributes, the mechanical barriers posed by the tumor stroma can be improved, facilitating robust immune cell penetration and activity, and thereby bolstering the tumor's susceptibility to immunotherapy. Ongoing clinical trials are evaluating these innovative treatments, particularly in combination with immunotherapies, with the aim of enhancing clinical outcomes for CRC patients afflicted by pronounced matrix stiffness.

Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy

The key role of matrix stiffness in colorectal cancer immunotherapy: mechanisms and therapeutic strategies

Targeting extracellular matrix stiffness and mechanotransducers to improve cancer therapy

Extracellular Matrix: Emerging Roles and Potential Therapeutic Targets for Breast Cancer.

Insights into the mechanisms, regulation, and therapeutic implications of extracellular matrix stiffness in cancer

Biomaterials to regulate tumor extracellular matrix in immunotherapy

Targeting extracellular matrix stiffness for cancer therapy

The Role of Matrix Stiffness in Cancer Stromal Cell Fate and Targeting Therapeutic Strategies

Extracellular matrix remodeling in the tumor immunity

Tumor-Associated Extracellular Matrix: How to Be a Potential Aide to Anti-tumor Immunotherapy?

Extracellular matrix and its therapeutic potential for cancer treatment

Extracellular matrix stiffness and tumor-associated macrophage polarization: new fields affecting immune exclusion

Targeting Extracellular Matrix Interaction in Gastrointestinal Cancer: Immune Modulation, Metabolic Reprogramming, and Therapeutic Strategies

Tumor stiffening reversion through collagen crosslinking inhibition improves T cell migration and anti-PD-1 treatment

Modulating Tumor Extracellular Matrix by Simultaneous Inhibition of Two Cancer Cell Receptors.

Matrix stiffness affects tumor-associated macrophage functional polarization and its potential in tumor therapy

Crosstalk between T lymphocyte and extracellular matrix in tumor microenvironment

Understanding the matrix: collagen modifications in tumors and their implications for immunotherapy

Mechanotransduction in Response to ECM Stiffening Impairs Cgas Immune Signaling in Tumor Cells.

Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments

Matrix Stiffness-Driven Cancer Progression and the Targeted Therapeutic Strategy